The Patent Finder

Kadmon Pharmaceuticals, LLC

Also on record
Records under this name other than patents Kadmon Pharmaceuticals, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to Kadmon Pharmaceuticals, LLC

PatentTitleStatus Expires Confidence
US 7,723,310Large Dose Ribavirin Formulations
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,479,533Inhibitors of Rho associated coiled-coil containing protein kinase
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,926,596Inhibitors of Rho Associated Coiled-Coil Containing Protein Kinase
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,874,624Stable trientine formulations
Lapsed on the fee record
Ended Dec 29, 2024 · From the USPTO record
Lapsed on the fee recordEnded Dec 29, 2024From the USPTO record
US 7,538,094Composition Containing Ribavirin and Use Thereof
Lapsed on the fee record
Ended May 26, 2021 · High confidence
Lapsed on the fee recordEnded May 26, 2021High confidence
US 6,720,000Process for Producing Wet Ribavirin Pellets
Term ended
Term ended Mar 19, 2021 · High confidence
Term endedTerm ended Mar 19, 2021High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited